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INTRODUCTION
Mycoplasma pneumoniae initially was identified in 1944 
as the pleuro-pulmonary like organism found in the spu-
tum of patients with primary atypical pneumonia.1,2 It is 
a common pathogen responsible for upper and lower re-
spiratory infections in young adults and school-aged chil-
dren.1,3-5 It usually has a self-limited course characterized by 
cough, headache, and fatigue.6 Respiratory infections includ-
ing bronchitis, bronchiolitis, community-acquired pneumo-
nia, and tracheobronchiolitis are common presentations.1,6,7 
Extrapulmonary manifestations have been described in 25% 
of Mycoplasma pneumoniae cases and they usually manifest 
in the presence or absence of lung infection.2 The presence of 
multiple extrapulmonary manifestations is considered a poor 
prognostic factor. These manifestations include neurologi-
cal, hematological, cardiac, gastrointestinal, or dermatologic 
findings.1-3,5-9 Hematological manifestations include hemolytic 
anemia, thrombocytopenic purpura, and disseminated intra-
vascular coagulation.2 When accompanied by respiratory dis-
ease, extrapulmonary manifestations tend to occur three or 
more days after the onset of respiratory disease and may last 
up to three weeks after resolution of the respiratory illness.1,2
We describe the first known adult case of Myco-
plasma pneumoniae presenting with pancytopenia.
CASE REPORT
A previously healthy 23-year-old Asian female presented dur-
ing mid-winter with a ten-day history of diarrhea and fever. She 
denied any other symptoms except for occasional cough of clear 
sputum. Her blood pressure on admission was 90/54 mmHg 
and her temperature was 101.2°F. Her physical exam was un-
remarkable. The white blood cell count was 1.1 K/uL with an 
absolute neutrophil count of 940 K/uL and absolute lymphocyte 
count of 90 K/uL. Hemoglobin was 9.2 g/dl with a mean corpus-
cular volume of 81.6 fL and platelet count 100 K/uL. Aspartate 
transaminase and alanine transaminase were elevated at 74 and 
116 U/L, respectively. Erythrocyte sedimentation rate (ESR) was 
23 mm/hr and C-reactive protein (CRP) was less than 0.5 mg/
dL. A chest x-ray revealed bilateral infiltrates, greater on the 
right side. Cultures of blood and sputum also were negative.
Respiratory virus panel PCR for influenza A subtype 
H1 and H3, influenza B, RSV subtype A and B, adenovi-
rus, rhinovirus, parainfluenza virus 1, 2, and 3, and human 
metapneumovirus were negative. Urine streptococcus pneu-
moniae and legionella pneumophilia group 1A and Histoplasma 
urine antigen were negative. Stool culture and studies for 
ova and parasites, occult blood, clostridium difficile toxin B 
PCR, giardia antigen, shiga toxin 1 and 2 also were negative. 
Direct Coombs test was positive with a low haptoglobin 
at 3 mg/dL (normal: 36 - 195), elevated lactate dehydroge-
nase at 680 U/L (normal: 98 - 192), elevated schistocyte count, 
and normal reticulocyte count indicative of autoimmune 
hemolytic anemia. Vitamin B12, iron panel, thyroid-stim-
ulating hormone, and folate levels were insignificant. Fer-
ritin level was elevated at 1528 ng/ml (normal: 11 - 307). Glu-
cose-6-phosphate dehydrogenase (G6PD), pyruvate kinase 
level, and hemoglobin electrophoresis were normal. Dissemi-
nated intravascular coagulation (DIC) panel was negative.
Bone marrow aspirate revealed complete and nondysplastic 
erythroid and myeloid maturation; megakaryocytes were absent. 
Flow cytometry showed no increase in blasts and no immunophe-
notypic evidence of lymphoma. Leukemia flow panel was nega-
tive. Bone marrow karyotype had no clonal abnormality noted.
Mycoplasma pneumonia IgG and IgM levels were positive at 
40,218 mg/dL and 1.23 mg/dL, respectively (reference range 0.00 
to 1.09). Chlamydia, parvovirus B19, and hepatitis serology were 
negative. Polymerase chain reaction (PCR) was negative for oth-
er causes of autoimmune hemolytic anemia, such as cytomegalo-
virus, Epstein-Barr virus, in addition to HIV 1 and 2 antibodies.
Cerebrospinal fluid studies, including cell count, bacterial, 
acid-fast bacillus, viral and fungal culture, immunofixation, en-
terovirus, and herpes simplex virus PCR were negative. West 
Nile IgG and IgM antibodies, Venereal Disease Research Labo-
ratory test, and cryptococcal antigen also were negative. C3 and 
C4 complement in blood were low. No blood parasites noted. 
The patient was treated with 500 mg azithromycin for one 
day followed by 250 mg for four days. She showed improve-
ment with resolution of symptoms, infiltrates, and neutro-
penia. A repeat complete blood count five days after com-
pletion of therapy revealed a white blood count of 5.7 K/
uL, hemoglobin of 8.6 g/dl, and a platelet count of 192 K/uL.
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DISCUSSION
 Mycoplasma pneumoniae infections traditionally involve the 
respiratory tract, manifesting a wide variety of symptoms 
ranging from productive cough to severe pneumonia. Extra-
pulmonary manifestations involving almost all organ sys-
tems have been reported. Narita classified the pathogenesis 
of extrapulmonary manifestations into three categories that 
are not always mutually exclusive.10 The direct type is medi-
ated by inflammatory cytokine released locally by bacterial 
cell membrane. The indirect type is based on immune modu-
lation and cross-reaction between human cells and bacterial 
cell components10 where cross-reactivity of anti-Mycoplasma 
pneumoniae antibodies causes immune-mediated damage.3 For 
instance, IgM autoantibodies directed against red blood cells 
have been proposed as the cause of cold-agglutinin hemolyt-
ic anemia. Moreover, central nervous system complications 
have been thought to result from autoantibodies against glu-
cocerebrosidase.7 Finally, the third type is a vascular occlusion 
where bacterium induces vasculitis and/or thrombosis.10 The 
described extrapulmonary manifestations can be classified on 
the basis of the proposed pathogenesis as shown in Table 1.11,12
Table 1. Extrapulmonary manifestations classified by 
proposed mechanisms. 
Extrapulmonary 
Manifestations
Direct Type Indirect Type Vascular 
Occlusion
Cardiovascular • Endocarditis
• Pericarditis
• Kawasaki Disease
• Myocarditis
• Aortic 
Thrombus
• Cardiac 
Thrombus
Dermatological • Erythema 
Multiforme
• Stevens-Johnsons 
Syndrome
• Urticaria
Digestive System • Early Onset 
Hepatitis
• Late Onset 
Hepatitis
• Pancreatitis
Hematological/
Hematopoietic
• Autoimmune 
Hemolytic Anemia
• Hemophagocytic 
Syndrome
• Infectious 
Mononucleosis
• Thrombocytope-
nic Purpura
• Disseminat-
ed Intravascu-
lar Coagulation
• Splenic 
Infarct
Neurological • Aseptic 
Meningitis
• Early Onset 
Encephalitis
• Acute Cerebellar 
Ataxia
• Guillain-Barre 
Syndrome
• Late Onset 
Encephalitis
• Psychologi-
cal Disorders
• Striatal 
Necrosis
• Stroke
• Thalamic 
Necrosis
 This report is the first known to describe pancytopenia in 
an adult as an extrapulmonary manifestation of Mycoplasma 
pneumoniae infection. Some cases reported leukocytosis with 
white blood cell count ranging from 26,000 to 56,000/mm3 
and rarely leukopenia with white count of 3,800/mm.3,9,13,14 
Some reports suggested a transient suppression of T-lym-
phocytes especially CD4+ T cells, and the immune system as 
a whole by unknown mechanisms.1 Hemophagocytic lym-
phohistiocytosis (HLH) also was reported as a manifesta-
tion of Mycoplasma,15 but the clinical presentation and bone 
marrow evaluation in our patient did not point to HLH.
 The patient was of Chinese origin. Her last visit to Asia was 
a few months before presentation. Mycoplasma extrapulmo-
nary infections from Asia have been reported, especially the 
southeast region. For instance, a similar case of mycoplasma 
pneumonia infection presenting with neutropenia, thrombocy-
topenia, and acute hepatitis was reported in a Taiwanese child 
in 2004,13 but no cases have been reported in adults. Proposed 
ethnic differences may account for the differences in distribu-
tion and manifestations between the western communities and 
Southeast Asia; such as the presentation of Kawasaki disease, 
infectious mononucleosis, and Mycoplasma infection.10 There 
might be a link between the ethnicity of this patient and her 
presentation with pancytopenia in the setting of Mycoplasma 
pulmonary infection. The underlying mechanism causing ex-
trapulmonary manifestations and, in particular, bone mar-
row suppression needs to be elucidated further. Genetic and/
or environmental factors might play a role in the clinical fea-
tures of Mycoplasma. A few reports of Mycoplasma in HIV 
positive patients have been mentioned, however, no definite 
conclusion was reached concerning whether immunosuppres-
sion alters the incidence or severity of mycoplasma infection.2
 Our patient received a five-day course of azithromycin 
and recovered. Supportive treatment also might be a reason-
able approach, whereby antibiotics and steroids are given 
on individual basis.1 Moreover, immune-modulatory thera-
peutics is entertained based on the hypothesis of an im-
mune-mediated role in the pathogenesis of this infection.2
CONCLUSION
 Despite the increasing knowledge about extrapulmonary 
manifestations of Mycoplasma, more research is needed in 
the areas of pathogenesis, epidemiological differences, host 
factors, and management. This case raised awareness and 
suspicion of possible Mycoplasma pneumonia infection in pa-
tients with bone marrow suppression and community ac-
quired pneumonia especially in patients of Asian descent.
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